Lexicon Pharmaceuticals, Inc.
LXRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001062822
No open-market purchases or sales by Lexicon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 149 institutions reported holding it in 13F filings for Q2 2026, worth $875.1M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Lexicon Pharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 127
- +9 vs. Q1 2024
- Shares held
- 279.0M
- +106.2M (+61.4%) vs. Q1 2024
- Total value
- $471.0M
- +$53.2M (+12.7%) vs. Q1 2024
- New holders
- 26
- 49 more added
- Sold out
- 17
- 21 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LXRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 149 | $875.1M |
| Q1 2026 | 137 | $504.5M |
| Q4 2025 | 126 | $299.5M |
| Q3 2025 | 124 | $344.4M |
| Q2 2025 | 123 | $242.9M |
| Q1 2025 | 127 | $122.5M |
| Q4 2024 | 127 | $220.1M |
| Q3 2024 | 137 | $453.1M |
| Q2 2024 | 127 | $471.0M |
| Q1 2024 | 118 | $417.8M |
| Q4 2023 | 106 | $279.8M |
| Q3 2023 | 112 | $205.8M |
| Q2 2023 | 123 | $438.2M |
| Q1 2023 | 104 | $353.8M |
| Q4 2022 | 105 | $280.5M |
| Q3 2022 | 98 | $357.3M |
| Q2 2022 | 86 | $221.0M |
| Q1 2022 | 101 | $251.3M |
| Q4 2021 | 110 | $478.9M |
| Q3 2021 | 96 | $583.0M |
| Q2 2021 | 107 | $540.2M |
| Q1 2021 | 107 | $711.5M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Lexicon Pharmaceuticals, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BBR Partners, LLC | 270,000 | $453.6K | 0.04% | +240,000+800.0% | Added |
| Alliancebernstein L.P. | 273,041 | $458.7K | 0.00% | +53,100+24.1% | Added |
| Morgan Stanley | 354,036 | $594.8K | 0.00% | +109,827+45.0% | Added |
| Goldman Sachs Group Inc | 373,431 | $627.4K | 0.00% | +217,217+139.1% | Added |
| Bank of New York Mellon Corp | 401,908 | $675.2K | 0.00% | +109,902+37.6% | Added |
| Hennion & Walsh Asset Management, Inc. | 542,899 | $912.1K | 0.05% | +542,899 | New |
| Millennium Management LLC | 597,321 | $1.00M | 0.00% | +63,137+11.8% | Added |
| Wellington Management Group LLP | 738,628 | $1.24M | 0.00% | +52,210+7.6% | Added |
| Northern Trust Corp | 997,528 | $1.68M | 0.00% | +130,972+15.1% | Added |
| Marshall Wace, LLP | 1,190,448 | $2.00M | 0.00% | +691,276+138.5% | Added |
| Charles Schwab Investment Management Inc | 1,359,148 | $2.28M | 0.00% | +478,025+54.3% | Added |
| Pinnacle Associates Ltd | 1,715,831 | $2.88M | 0.05% | −31,999−1.8% | Reduced |
| Opaleye Management Inc. | 1,875,000 | $3.15M | 0.72% | +1,875,000 | New |
| Schonfeld Strategic Advisors LLC | 571,492 | $3.24M | 0.03% | −388,658−40.5% | Reduced |
| Ameriprise Financial Inc | 2,092,710 | $3.52M | 0.00% | +674,760+47.6% | Added |
| Nantahala Capital Management, LLC | 2,304,150 | $3.87M | 0.39% | +2,304,150 | New |
| State Street Corp | 2,313,477 | $3.89M | 0.00% | +325,967+16.4% | Added |
| NEA Management Company, LLC | 2,382,286 | $4.00M | 0.30% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,409,456 | $4.05M | 0.00% | +2,274,979+1,691.7% | Added |
| Geode Capital Management, LLC | 3,250,535 | $5.46M | 0.00% | +861,398+36.1% | Added |
| Point72 Asset Management, L.P. | 4,121,191 | $6.92M | 0.02% | +3,536,805+605.2% | Added |
| OrbiMed Advisors LLC | 5,846,100 | $9.82M | 0.21% | +2,304,100+65.1% | Added |
| Vanguard Group Inc | 7,675,125 | $12.9M | 0.00% | +1,273,900+19.9% | Added |
| Braidwell LP | 8,294,950 | $13.9M | 0.44% | +8,294,950 | New |
| BlackRock Inc. | 9,890,153 | $16.6M | 0.00% | +2,196,876+28.6% | Added |
| FMR LLC | 38,687,123 | $65.0M | 0.00% | +24,793,061+178.4% | Added |
| Artal Group S.A. | 175,099,384 | $294.2M | 7.55% | +57,546,100+49.0% | Added |
| BVF Inc | 0 | $0 | 0.00% | −1,686,924−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −1,404,928−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −319,058−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −293,333−100.0% | Sold out |
| Boulder Hill Capital Management LP | 0 | $0 | 0.00% | −256,400−100.0% | Sold out |
| Natixis Advisors, L.P. | 0 | $0 | 0.00% | −86,094−100.0% | Sold out |
| Lazard Freres Gestion S.A.S. | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −45,658−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −43,591−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −34,433−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −29,400−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −16,965−100.0% | Sold out |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −10,675−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −2,495−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −21−100.0% | Sold out |